Why Diagnose Pulmonary Hypertension Early
Pulmonary hypertension is a serious, debilitating, and often fatal progressive condition where the blood pressure in the lungs rises to dangerously high levels, ultimately resulting in right heart failure.
Without treatment, the median survival rate of patients with pulmonary hypertension is approximately 2.8 years.
Proper treatment has been found to extend life and improve quality of life, however early intervention remains the key to maximizing treatment efficacy and patient outcomes.
When an accurate PH diagnosis accompanied by appropriate treatment is achieved early in the disease progression (functional classes I & II), patients report fewer limitations and greater quality of life. For many this means maintaining the ability to work and continuing to enjoy family and social activities, as well as hobbies. Unfortunately, the REVEAL Registry shows that patients displaying milder impairment are among the groups experiencing the greatest diagnostic delays. Through the Early Diagnosis Campaign, PHA is working to change that.